Unknown

Dataset Information

0

Reproducibility of serologic assays for influenza virus A (H5N1).


ABSTRACT: Hemagglutination-inhibition (HI) and neutralization are used to evaluate vaccines against influenza virus A (H5N1); however, poor standardization leads to interlaboratory variation of results. A candidate antibody standard (07/150) was prepared from pooled plasma of persons given clade 1 A/Vietnam/1194/2004 vaccine. To test human and sheep antiserum, 15 laboratories used HI and neutralization and reassortant A/Vietnam/1194/2004, A/turkey/Turkey/1/2005 (clade 2.2), and A/Anhui/1/2005 (clade 2.3.4) viruses. Interlaboratory variation was observed for both assays, but when titers were expressed relative to 07/150, overall percentage geometric coefficient of variation for A/Vietnam/1194/2004 was reduced from 125% to 61% for HI and from 183% to 81% for neutralization. Lack of reduced variability to clade 2 antigens suggested the need for clade-specific standards. Sheep antiserum as a standard did not reliably reduce variability. The World Health Organization has established 07/150 as an international standard for antibody to clade 1 subtype H5 and has an assigned potency of 1,000 IU/ampoule.

SUBMITTER: Stephenson I 

PROVIDER: S-EPMC2815968 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| PRJNA381590 | ENA
| PRJNA248762 | ENA
| PRJNA342929 | ENA
| S-EPMC5124960 | biostudies-literature
| S-EPMC2660695 | biostudies-literature
| S-EPMC4766899 | biostudies-literature
| S-EPMC6813000 | biostudies-literature
| S-EPMC4442345 | biostudies-literature
| S-EPMC4634607 | biostudies-other
| S-EPMC3636560 | biostudies-other